Kidney Stones: Causes, Symptoms, Treatment & Prevention

Kidney stones are crystalline concretions that form when urine becomes persistently supersaturated with poorly soluble salts, most often calcium oxalate, calcium phosphate, uric acid, struvite, or cystine. The biochemical pathway moves through nucleation, crystal growth, and aggregation; over weeks to months these aggregates anchor on Randall’s plaques in the renal papillae, accumulate, and may dislodge into the collecting system. Symptomatic disease begins when a stone migrates into the ureter and obstructs urine flow, generating intense colic from upstream renal-pelvic pressure and prostaglandin-mediated smooth-muscle spasm.

Nephrolithiasis is best framed as a chronic metabolic disorder with episodic acute presentations, not a one-off event. Lifetime prevalence approaches 10–11% in adults across high-income countries, peaks between the third and sixth decades, and is a little more common in men, although the gap has narrowed with rising obesity and dietary shifts. After a first stone, recurrence sits between 30% and 50% within five years without targeted prevention, and recurrent disease drives a measurable burden of chronic kidney disease, hypertension, and bone-mineral changes, which is why clinicians treat the acute attack and the next attack at the same time.

Stone chemistry shapes both prevention strategy and the choice of metabolic workup; stone size and location predict whether the body will pass the stone or whether intervention is needed. Send any captured fragment for compositional analysis—even from a first stone—because therapy varies sharply between calcium-, urate-, infection-, and cystine-type disease.

↔On a small screen, swipe or scroll sideways to see the full table.

Size groups read across guidelines (NICE NG118, EAU, AUA) as: under 5 mm, 5–10 mm, and over 10 mm. Spontaneous passage rates roughly approximate 70–80%, 50%, and under 25% respectively, with distal ureteric stones outperforming proximal ones at every band. Use the table below to anchor counselling at discharge and to set realistic timelines.

↔On a small screen, swipe or scroll sideways to see the full table.

These ranges are pooled estimates—local practice, comorbidity, occupational requirements, and patient preference change the threshold for intervention.

The cardinal presentation is sudden, severe colic that radiates from the loin towards the groin, often described as the worst pain a patient has ever experienced and worse than labour or fracture pain in some surveys. Patients are typically restless rather than still, in contrast to the “lie-still” posture of peritonitis. Symptom intensity does not reliably correlate with stone size.

Typical presentation

• Unilateral flank or kidney pain radiating to the ipsilateral groin or testicle/labia as the stone descends.
• Visible or microscopic blood in urine in 80–90% of patients—absence does not exclude a stone.
• Nausea and vomiting from shared splanchnic innervation.
• Storage symptoms (urgency, frequent urination, dysuria) when the stone reaches the vesico-ureteric junction.

Atypical or red-flag features

• Fever, rigors, or new confusion—suspect infected obstruction.
• Anuria in a patient with a single functioning kidney or known bilateral disease.
• Pain extending beyond 4–6 hours despite a multimodal regimen, prompting reassessment of the diagnosis.
• Pregnancy with flank pain—lower the threshold for ultrasound and urology input; CT carries fetal radiation considerations.
• Older adults with vague abdominal pain—consider an aortic catastrophe (for example abdominal aortic aneurysm) before anchoring on “probable colic”.

Kidney stones form at the intersection of urine chemistry, fluid balance, and dietary or systemic drivers. The shared mechanism is supersaturation: when promoter solutes (calcium, oxalate, urate, cystine) outweigh inhibitors (citrate, magnesium, pyrophosphate) within a low urine volume, crystals nucleate and grow. Identifying which lever to pull is the work of the metabolic workup, but the everyday risk profiles are recognisable on history alone.

Modifiable drivers

• Low fluid intake, hot climates, or occupations that limit access to fluids and bathroom breaks (drivers, surgeons, factory workers).
• High dietary sodium, animal-protein excess, and added-sugar drinks—each independently raises urine calcium or urate.
• Obesity, metabolic syndrome, and type 2 diabetes—all promote uric-acid stone formation through low urinary pH.
• Recurrent urinary tract infection with urea-splitting organisms—drives struvite stone formation.
• Drug-related: high-dose vitamin C, calcium supplements taken between meals, topiramate, indinavir, sulfadiazine, loop diuretics in some contexts.

Structural and metabolic baseline

• Idiopathic hypercalciuria (most common metabolic abnormality identified on workup).
• Primary hyperparathyroidism—screen with serum calcium and parathyroid hormone when calcium is high.
• Distal renal tubular acidosis with persistent alkaline urine and hypokalaemia.
• Inherited disorders such as cystinuria and primary hyperoxaluria.
• Malabsorption from inflammatory bowel disease, bariatric bypass, or chronic diarrhoea (enteric hyperoxaluria).
• Anatomical anomalies: medullary sponge kidney, horseshoe kidney, ureteropelvic-junction obstruction.

Clinical assessment

Take a focused history (onset, radiation, prior stones, family history, fluid and dietary patterns, occupational exposures, current medications), check vital signs for sepsis cues, and palpate for costovertebral angle tenderness. Always perform a bedside abdominal assessment to exclude peritonism and the older-adult vascular catastrophe. Do not anchor on “same as last time” without rechecking the basics.

Laboratory investigations

• Urinalysis with microscopy: haematuria, leukocyte esterase, nitrites, pH; collect via clean-catch specimen when feasible.
• Urine culture when infection cannot be excluded by dipstick, especially before any urological intervention.
• Serum creatinine, electrolytes, and serum calcium—screen for dehydration, eGFR changes, and hypercalcaemia.
• Full blood count and CRP when sepsis is on the differential; add lactate per local sepsis pathway.
• Chemistry of any captured fragment via the laboratory’s stone-analysis service.

Imaging

• Non-contrast CT KUB: first-line in non-pregnant adults with suspected ureteric colic—high sensitivity (≈95–98%) and specificity, identifies stone size, location, hydronephrosis, and alternative diagnoses.
• Ultrasound of kidneys and bladder: first-line in pregnancy, in children, and as a low-radiation screen; reliably detects hydronephrosis and stones at the ureteropelvic and ureterovesical junctions.
• Plain KUB X-ray: useful for follow-up of radiopaque stones already characterised on CT; not for primary diagnosis.
• Functional studies (MAG-3 renogram, dual-energy CT) for selected recurrent or complex cases via specialist services.

Recurrent or high-risk metabolic evaluation

For recurrent stones, a single functioning kidney, paediatric stones, family history, struvite or cystine disease, arrange a basic metabolic workup (serum calcium, phosphate, urate, parathyroid hormone, bicarbonate) and a 24-hour urine for volume, calcium, oxalate, citrate, urate, sodium, and creatinine. Patients should keep their normal diet and fluid intake during collection; many programmes prefer two collections to mitigate day-to-day variation.

Acute flank pain has a long and dangerous differential. Anchor early on the bedside features that distinguish each mimic, and never close the case without considering vascular and surgical alternatives in the older adult.

↔On a small screen, swipe or scroll sideways to see the full table.

1. Recognise: Sudden flank-to-groin pain, vital signs, and a directed pain assessment (severity, restlessness, radiation, comorbidities). Prioritise sepsis screening before fluid challenge or analgesia.
2. Stabilise: Establish IV access, give first-line analgesia (parenteral NSAID unless contraindicated) plus an antiemetic, and add cautious fluids when volume depleted; avoid forced diuresis.
3. Confirm: Obtain non-contrast CT KUB in non-pregnant adults; ultrasound first in pregnancy and paediatrics. Document stone size, side, exact location, and hydronephrosis grade.
4. Risk-stratify: Sort patients into uncomplicated outpatient management, admission for unrelieved pain or vomiting, or urological emergency for fever / sepsis / bilateral or single-kidney obstruction.
5. Treat: Pain bundle, MET if 5–10 mm distal ureteric, definitive intervention if >10 mm or non-passage at 4–6 weeks; urgent decompression for infected obstruction.
6. Plan prevention: Strain-and-save, hydration target ≥2.0–2.5 L urine output/day, dietary advice, and metabolic workup where indicated. Book primary care or urology follow-up.

First-line analgesia and supportive care

• NSAID first: parenteral or intramuscular diclofenac, IV ketorolac, or oral ibuprofen when tolerated—avoid in stage ≥3 CKD, active GI bleeding, asthma sensitivity, or third-trimester pregnancy. Confirm renal function before re-dosing.
• Acetaminophen as opioid-sparing adjunct.
• Short-course opioid such as morphine when NSAID is unsuitable or pain breaks through; titrate to effect with vigilance for sedation and emesis.
• Antiemetic such as ondansetron; encourage oral fluids when not vomiting, IV crystalloid only if dehydrated—avoid forced diuresis as a way to “flush” the stone.
• Discharge with strain-and-save instructions and clear safety-net contacts.

Medical expulsive therapy (MET)

• Selective alpha-blocker: tamsulosin 0.4 mg once daily for up to 4 weeks—best evidence for distal ureteric stones 5–10 mm; counsel on orthostatic hypotension and ejaculatory effects.
• Calcium-channel blocker: nifedipine as an alternative where alpha-blocker is contraindicated.
• Re-image and reassess at 4 weeks; refer for definitive intervention if not passing or symptoms persist.

Antimicrobial therapy

• Empirical broad-spectrum cover (for example ceftriaxone per local antibiogram) for confirmed infection or sepsis with obstruction; rationalise to culture-directed therapy at 48 hours.
• Oral fluoroquinolone such as ciprofloxacin only when local resistance, allergy profile, and severity permit—watch tendon and QT cautions.
• Avoid pretreating uncomplicated colic with antibiotics; pyuria alone without infection is common with crystals in the urine.

Urological intervention

Choice of definitive procedure depends on stone size, location, composition, anatomy, and local expertise:

• Ureteroscopy with holmium laser fragmentation: increasingly first-line for ureteric and many renal stones, including in pregnancy.
• Extracorporeal shock-wave lithotripsy (SWL): less invasive, avoids anaesthesia in some centres, but lower stone-free rates for hard or distal stones.
• Percutaneous nephrolithotomy (PCNL): definitive option for stones >20 mm, complex staghorn, or after failed less-invasive therapy.
• Emergency drainage: ureteric stent or percutaneous nephrostomy when sepsis, AKI, or unrelieved pain demand decompression before definitive treatment.

Special populations

• Pregnancy: ultrasound first, NSAIDs avoided after 30 weeks, urology liaison early; ureteric stenting or ureteroscopy preferred over SWL.
• Paediatrics: weight-based dosing, low-radiation imaging, early metabolic workup—paediatric urology services lead.
• Single functioning kidney or transplant: lower threshold for admission, earlier imaging, and earlier urology input; AKI risk dominates.
• Older adults and frailty: balance opioid risks (delirium, falls) and NSAID risks (renal, GI, cardiovascular); start lower, titrate carefully.

• Pain reassessment cadence: Use a structured pain assessment tool every 15–30 minutes during initial titration; document response, sedation score, and any adverse effect after each dose.
• Output and obstruction monitoring: Track urinary output and intake/output; a sudden fall with a single functioning kidney is a same-day surgical issue.
• Bladder retention check: Use a bladder scan when post-void residual is unclear—not every flank pain with low output is obstructive uropathy.
• Lab cadence: Recheck creatinine within 24–48 h of admission or after contrast exposure; trend electrolytes if vomiting or diuretics in play; review WCC and CRP if sepsis was on the differential.
• Medicines review: Reconcile potassium-rich supplements, magnesium products, and over-the-counter calcium intake; check for high-risk drugs (topiramate, indinavir, sulfadiazine, high-dose vitamin C).
• Documentation: Stone size and side, hydronephrosis grade, working diagnosis, analgesic ladder used, sepsis screen, urology disposition, and follow-up plan—all need to read clearly on the next handover.
• Referral thresholds: Same-day urology for sepsis, single-kidney obstruction, pregnancy, anuria; outpatient urology for >10 mm stones, recurrent stones, or non-passage at 4–6 weeks.

• Pyonephrosis and urosepsis from infected obstruction.
• Obstructive acute kidney injury, particularly with bilateral disease or single functioning kidney.
• Long-term loss of renal parenchyma in untreated chronic obstruction.
• Recurrent stones and progressive chronic kidney disease.
• Procedural complications (ureteric injury, sepsis after instrumentation, bleeding after PCNL).
• Persistent storage symptoms or stent-related discomfort during conservative passage or post-procedure.

Recurrence prevention is led by hydration and dietary tweaks, then layered with stone-type-specific therapy when metabolic workup indicates. Aim for a urine output of at least 2.0–2.5 L per day, which usually corresponds to ~2.5–3.0 L of fluid intake spread across the day. Keep dietary calcium normal (do not restrict—calcium binds dietary oxalate in the gut), reduce sodium and animal-protein excess, and limit added-sugar drinks.

• Calcium-stone formers with hypercalciuria: thiazide diuretic such as hydrochlorothiazide; monitor potassium and sodium; supplement potassium when needed.
• Calcium-stone formers with hypocitraturia or distal RTA: potassium citrate where available.
• Uric-acid stones: urinary alkalinisation with potassium citrate; allopurinol if hyperuricosuria persists or in gout overlap.
• Struvite stones: complete surgical clearance plus targeted antimicrobials and long-term monitoring for recurrence.
• Cystine stones: high urine output, urinary alkalinisation, thiol-binding agents under specialist supervision.
• All patients: address obesity and metabolic syndrome with weight management, glycaemic control where relevant, and review of drugs that promote stones.

Most uncomplicated stones pass without intervention within four to six weeks, and acute pain usually resolves within 24–72 hours of effective analgesia. Long-term outlook depends on adherence to prevention: untreated, recurrence sits between 30% and 50% at five years; structured prevention more than halves that risk in trial populations. Recurrent stone formers carry a measurable excess of chronic kidney disease, hypertension, and bone-mineral changes, particularly when stones are bilateral, large, or struvite. Counsel patients that nephrolithiasis is a chronic condition with episodic attacks rather than a one-off event.

• Treat pain quickly and reassess: a writhing patient who suddenly settles after analgesia is the goal, but a patient who suddenly settles without analgesia and develops new fever may have transitioned into sepsis with falling perfusion.
• Urinary dipstick negative for blood does not exclude a stone—10–15% of patients have no haematuria on first sample.
• If colic recurs after “stone passage,” ask whether the fragment was actually retrieved or whether residual stones remain. Encourage patients to keep using the strainer until pain is gone for 48 hours.
• Check that patients understand which warning signs need same-day review—safety-netting in writing reduces avoidable readmission.
• For older patients on warfarin or DOACs, NSAIDs raise bleeding risk; choose an opioid-sparing alternative and document the reasoning.
• Stent symptoms after intervention can mimic ongoing stone disease—ensure patients have direct contact with the urology service rather than re-presenting to the emergency department.

• Vital signs: early-warning score with attention to temperature, heart rate, and lactate trend in any septic-feature patient.
• Pain: validated tool every 15–30 minutes during titration; reassess sedation, respiratory rate, and nausea after each opioid.
• Urine output and colour: hourly when sepsis is suspected or single kidney; encourage straining at every void.
• Hydration: oral first when tolerated; IV crystalloid for documented dehydration—avoid forced diuresis.
• Renal function trajectory: repeat creatinine within 24–48 h after admission or contrast.
• Adverse events: NSAID gastric symptoms, opioid sedation, alpha-blocker dizziness, antibiotic reactions.
• Discharge readiness: tolerating oral analgesia and fluids, vital signs stable, urology and primary-care follow-up booked, written safety-net advice provided.

• Fever ≥38 °C, rigors, confusion, or new tachycardia/hypotension with flank pain.
• Pain unresponsive to a multimodal regimen after a structured trial.
• Anuria, especially in a patient with a single functioning kidney or known stones bilaterally.
• Persistent vomiting preventing oral intake or oral analgesia.
• Pregnant patient with suspected colic—any flank pain warrants imaging and obstetric/urology liaison.
• Signs of sepsis after recent urological instrumentation.

Objective triggers for senior or critical-care review include rising lactate, falling Glasgow Coma Scale, mean arterial pressure under 65 mmHg despite fluids, urine output persistently below 0.5 mL/kg/h, or new oxygen requirement. Activate your local sepsis or rapid-response pathway when criteria are met, take cultures and lactate before broad-spectrum antibiotics, and call urology or interventional radiology for same-day decompression if obstruction is the source. Document time of escalation, who attended, what was done, and reassessment timing—the audit trail matters for both patient safety and learning.

Nursing-priority lens (NCSBN Clinical Judgment Measurement Model): recognise cues → analyse cues → prioritise hypotheses → generate solutions → take safe action → evaluate outcomes. These NCLEX-style clinical judgment practice items rotate through priority decisions, SATA recognition, deterioration trends, multi-patient triage, ordered response, matrix matching, and cloze drops focused on stone-size passage prediction, NSAID-first analgesia, medical expulsive therapy with tamsulosin, CT KUB triage, and the obstructed-infected stone red flag. Hit Check answers for the rationale layer.